| Literature DB >> 26637796 |
Jacqueline G O'Rourke1, Laurent Bogdanik2, A K M G Muhammad1, Tania F Gendron3, Kevin J Kim1, Andrew Austin2, Janet Cady4, Elaine Y Liu5, Jonah Zarrow1, Sharday Grant1, Ritchie Ho1, Shaughn Bell1, Sharon Carmona1, Megan Simpkinson1, Deepti Lall1, Kathryn Wu1, Lillian Daughrity3, Dennis W Dickson3, Matthew B Harms4, Leonard Petrucelli3, Edward B Lee5, Cathleen M Lutz2, Robert H Baloh6.
Abstract
Noncoding expansions of a hexanucleotide repeat (GGGGCC) in the C9orf72 gene are the most common cause of familial amyotrophic lateral sclerosis and frontotemporal dementia. Here we report transgenic mice carrying a bacterial artificial chromosome (BAC) containing the full human C9orf72 gene with either a normal allele (15 repeats) or disease-associated expansion (∼100-1,000 repeats; C9-BACexp). C9-BACexp mice displayed pathologic features seen in C9orf72 expansion patients, including widespread RNA foci and repeat-associated non-ATG (RAN) translated dipeptides, which were suppressed by antisense oligonucleotides targeting human C9orf72. Nucleolin distribution was altered, supporting that either C9orf72 transcripts or RAN dipeptides promote nucleolar dysfunction. Despite early and widespread production of RNA foci and RAN dipeptides in C9-BACexp mice, behavioral abnormalities and neurodegeneration were not observed even at advanced ages, supporting the hypothesis that RNA foci and RAN dipeptides occur presymptomatically and are not sufficient to drive neurodegeneration in mice at levels seen in patients.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26637796 PMCID: PMC4672384 DOI: 10.1016/j.neuron.2015.10.027
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173